Literature DB >> 18208796

Prognostic factors in cancer of unknown primary site.

A Muñoz, N Fuente, I Rubio, J Ferreiro, A Martínez-Bueno, G López-Vivanco.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18208796     DOI： 10.1007/s12094-008-0156-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  6 in total

1.  Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site.

Authors:  Stéphane Culine; Andrew Kramar; Mahasti Saghatchian; Roland Bugat; Thierry Lesimple; Alain Lortholary; Yacine Merrouche; Agnès Laplanche; Karim Fizazi
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

2.  Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

Authors:  C H Köhne; D Cunningham; F Di Costanzo; B Glimelius; G Blijham; E Aranda; W Scheithauer; P Rougier; M Palmer; J Wils; B Baron; F Pignatti; P Schöffski; S Micheel; H Hecker
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

3.  Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.

Authors:  J D Hainsworth; J B Erland; L A Kalman; M T Schreeder; F A Greco
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

4.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

5.  Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.

Authors:  J Ponce Lorenzo; A Segura Huerta; R Díaz Beveridge; A Giménez Ortiz; F Aparisi Aparisi; T Fleitas Kanonnikoff; P Richart Aznar; H de la Cueva Sapiña; J Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2007-07       Impact factor: 3.405

6.  [Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy].

Authors:  Alberto Muñoz; Natalia Fuente; Ramón Barceló; Itziar Rubio; Josefa Ferreiro; Guillermo López Vivanco
Journal:  Med Clin (Barc)       Date:  2004-02-21       Impact factor: 1.725
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.